Bone health management varies across hospitals for older women with early breast cancer who have inconsistent bone density ...

A 54-year-old patient’s routine mammogram finds a 6-mm breast nodule that histology confirms as kidney cancer metastasis, 3 ...

New AI technology can spot breast cancer in MRI scans more accurately than current digital methods, while also pinpointing ...

Cassandra and Katelyn Harding suffered the loss of their mother before both being diagnosed with rare osteosarcoma ...

Gedatolisib combined with Faslodex and Ibrance improved progression-free survival in patients with advanced breast cancer ...

A study published in The Annals of Family Medicine examined if gaining housing increased rates of colorectal and breast ...

A phase 3 trial of Celcuity’s breast cancer combination has hit its primary endpoints, blasting past the biotech’s bar for ...

Celcuity shares soar 186% after Phase 3 breast cancer trial shows triple therapy delays disease by over 7 months.

At a stroke, the data gives Celcuity a potential advantage over already-marketed oral PI3K inhibitors like Novartis' Piqray/Vijoice (alpelisib) and Roche's Itovebi (inavolisib), which are currently ...

Celcuity shares jump as gedatolisib shows strong efficacy in HR+/HER2- breast cancer Phase 3 trial, with FDA filing expected ...

A new documentary shines light on battling breast cancer. "One in Eight" shares the journey of 10 women living in and around ...

A new study reports that mice shed about 20% of their body weight and saw their breast cancer tumors decrease after getting ...